Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Sarcomatoid Variant of Bladder Carcinoma: A Case Report

Sarcomatoid Variant of Bladder Carcinoma: A Case Report A 59-year-old man was referred to our hospital complaining of asymptomatic gross hematuria. Cystoscopy revealed a papillary tumor 8 cm in diameter filling the bladder. The patient underwent transurethral resection of the bladder tumor. The pathological findings revealed the sarcomatoid variant of urothelial carcinoma with a heterologous osteosarcomatous element. He had no metastasis according to our imaging analyses; thus, we planned radical cystectomy after two courses of neoadjuvant chemotherapy (gemcitabine and cisplatin). Following chemotherapy, enlarged pelvic lymph nodes were noted, and extremely aggressive local progression of the bladder tumor was confirmed. The patient ultimately died 6 months after his initial visit to our hospital. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Case Reports in Oncology Karger

Sarcomatoid Variant of Bladder Carcinoma: A Case Report

Download PDF
5 pages

Loading next page...
 
/lp/karger/sarcomatoid-variant-of-bladder-carcinoma-a-case-report-wiDxyd0pv0

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Karger
Copyright
© 2018 The Author(s). Published by S. Karger AG, Basel
eISSN
1662-6575
DOI
10.1159/000492779
Publisher site
See Article on Publisher Site

Abstract

A 59-year-old man was referred to our hospital complaining of asymptomatic gross hematuria. Cystoscopy revealed a papillary tumor 8 cm in diameter filling the bladder. The patient underwent transurethral resection of the bladder tumor. The pathological findings revealed the sarcomatoid variant of urothelial carcinoma with a heterologous osteosarcomatous element. He had no metastasis according to our imaging analyses; thus, we planned radical cystectomy after two courses of neoadjuvant chemotherapy (gemcitabine and cisplatin). Following chemotherapy, enlarged pelvic lymph nodes were noted, and extremely aggressive local progression of the bladder tumor was confirmed. The patient ultimately died 6 months after his initial visit to our hospital.

Journal

Case Reports in Oncology – Karger

Published: Jan 1, 2018

Keywords: Sarcomatoid variant; Bladder tumor; Bladder cancer; Cisplatin; Gemcitabine

References

  • Cancer statistics, 2010
    Jemal, A; Siegel, R; Xu, J; Ward, E
  • A low psoas muscle volume correlates with a longer hospitalization after radical cystectomy
    Saitoh-Maeda, Y; Kawahara, T; Miyoshi, Y; Tsutsumi, S; Takamoto, D; Shimokihara, K
  • The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System
    Epstein, JI; Egevad, L; Amin, MB; Delahunt, B; Srigley, JR; Humphrey, PA
  • Expression of receptor activator of nuclear factor kappa B ligand in bladder cancer
    Ohtaka, M; Kawahara, T; Ishiguro, Y; Sharma, M; Yao, M; Miyamoto, H
  • Editorial Comment to High neutrophil-to-lymphocyte ratio predicts worse overall survival in patients with advanced/metastatic urothelial bladder cancer
    Ohno, Y
  • Contemporary rates of pathological features and mortality for adenocarcinoma of the urinary bladder in the USA
    Zaffuto, E; Gazdovich, S; Leyh-Bannurah, SR; Huland, H; Abdollah, F; Shariat, SF
  • Carcinosarcoma and sarcomatoid carcinoma of the bladder: clinicopathological study of 41 cases
    Lopez-Beltran, A; Pacelli, A; Rothenberg, HJ; Wollan, PC; Zincke, H; Blute, ML